The Bioanalytical Method Validation (Draft Guidance 2013) represents the Food and Drug Administration’s current thinking on this topic and was published in September 2013. Since then, almost all regulated bioanalytical methods have been validated based on this guidance. This guidance provides assistance to sponsors of investigational new drug applications (
Course Objectives:
• Understand the basic FDA guidelines for method validation described in the 2013 Draft GFI Document.
• Understand the significance of a bioanalytical method validation and its applicability to different aspects of drug development.
• Understand how to interpret the Draft Guidance and use it to establish validation parameters and acceptance limits.
• Understand the difference between a full, partial and cross-validation.
• Know how to apply the bioanalytical method validation to testing for routine drug analysis situations.
• Understand the basics of how to draft an SOP describing the Bioanalytical Method Validation process.
Course Outline:
• FDA guidelines for bioanalytical method validation.
• Learning from the Crystal City FDA/Industry conference report.
• Logistics of validation.
• Development of a master plan and SOP for validation.
• Preparation and use of reference standards and equipment.
• Defining parameters and acceptance limits.
• Defining validation experiments.
• Considerations for Microbiological and Ligand-binding Assays.
• To re-validate or not after method changes
• Transferring and using the method for routine analysis.
What You Get:
• Training Materials
• Live Q&A Session with our Expert
• Participation Certificate
• Access to Signup Community (Optional)
• Reward Points
Who Will Benefit:
• Managers and analysts in bioanalytical laboratories
• QA managers and personnel
• Validation specialists
• Consultants, scientists, technologists, and engineers in the pharmaceutical industry.
• Bioanalytical scientists
• Biotech R&D staff
• Outsourcing Professionals
• Biopharmaceutical Consultants
Analyzing Assay Validation for Clinical Diagnostics
Get Instant Access 60 Minutes View Program |
General Data Protection Regulation (GDPR): Compliance for Clinical Trials
Get Instant Access 60 Minutes View Program |
Protocol Deviations: Documenting, Managing, and Reporting
Get Instant Access 60 Minutes View Program |
Adverse Event Reporting Understanding Regulatory Reporting Requirements
Get Instant Access 60 Minutes View Program |
The Sunshine Act: Reporting for Clinical Trials
Get Instant Access 60 Minutes View Program |
Get Instant Access On-Demand Access
Preparing for the ICE Storm: What to Do During I 9 Audits and ICE Raids
Janette S. Levey
Human Resources
Get Instant Access On-Demand Access
OSHA Inspections and Investigations-How to Manage Them
Irwin Dobrushin
Environment Health and Safety | OSHA
Get Instant Access On-Demand Access
29 CFR 1904: OSHA's New Injury Recordkeeping E-Submission Rule
Occupational Safety and Health Administration
Get Instant Access On-Demand Access
Working with Excel Databases: Sort, Filter, Subtotal and More
Cathy Horwitz
Cross Industry | Skill Enhancement
Get Instant Access On-Demand Access
Writing Audit Reports
Jonnie T. Keith CIA, CFE, CGAP, CICA
Governance, Risk and Compliance
Get Instant Access On-Demand Access
BSA Reporting Requirements
Banking and Financial Services Industry
Get Instant Access On-Demand Access
Human Factors-Usability Based on ISO 62366
Medical Device | Diagnostic | Pharmaceutical | Biologics fields
Get Instant Access On-Demand Access
Chat GPT for Project Managers
Charles H. Paul
All FDA Regulated Industry